"Is dopamine involved in Alzheimer's disease?" (Q26851680)

Frontiers in Aging Neuroscience

published in

1 reference

1 reference

252

1 reference

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The reward circuit: linking primate anatomy and human imaging

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Nicotinic receptors in neurodegeneration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The amyloid precursor protein: a biochemical enigma in brain development, function and disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Frailty among Alzheimer's disease patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Can we clinically diagnose dementia with Lewy bodies yet?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Dopamine D₂-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The relationship between subcortical tau pathology and Alzheimer's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Rapidly progressive Alzheimer disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Amyloid-β associated cortical thinning in clinically normal elderly

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The cholinergic system in aging and neuronal degeneration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Functional alterations in memory networks in early Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Formation and development of Lewy pathology: a critical update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Does Alzheimer's disease begin in the brainstem?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Comparison of 18F-FDG and PiB PET in cognitive impairment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Neuropathology of parkinsonism in patients with pure Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Living on the edge with too many mouths to feed: why dopamine neurons die.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

The primate substantia nigra and VTA: integrative circuitry and function.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Decreased dopamine transporters with age in health human subjects.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.

31 May 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Clinical symptoms and symptom signatures of Alzheimer's disease subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Extrapyramidal signs in patients with probable Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Human striatum: the distribution of neurofibrillary tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Apathy predicts more severe parkinsonism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

CSF biomarkers in relationship to cognitive profiles in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Apathy syndrome in Alzheimer's disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

Complexity of a human being: changes with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00252

A non-alpha7 nicotinic acetylcholine receptor modulates excitatory input to hippocampal CA1 interneurons

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4174765

Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309431

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Brain dopamine D-2 receptors in senile dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309431

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309431

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FNAGI.2014.00252

1 reference

release_5h2z4khtdbbhrljv23mhopeuzy

Fatcat ID

0 references

1 reference

1 reference

PubMed publication ID

25309431

1 reference